Increased serum resistin levels in patients with coronary slow flow phenomenon       
Yazarlar (9)
A. Çanga
Rize Training & Research Hospital, Türkiye
M. Çetin
Rize Training & Research Hospital, Türkiye
S. A. Kocaman
Rize Training & Research Hospital, Türkiye
M. E. Durakoǧlugil
Recep Tayyip Erdogan University, Türkiye
Prof. Dr. Aynur KIRBAŞ Recep Tayyip Erdogan University, Türkiye
T. Erdoǧan
Recep Tayyip Erdogan University, Türkiye
A. Temiz
Rize Training & Research Hospital, Türkiye
A. Yilmaz
Recep Tayyip Erdogan University, Türkiye
Y. Çiçek
Recep Tayyip Erdogan University, Türkiye
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı Herz
Dergi ISSN 0340-9937 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce
Basım Tarihi 11-2013
Cilt No 38
Sayı 7
Sayfalar 773 / 778
DOI Numarası 10.1007/s00059-013-3758-6
Makale Linki http://link.springer.com/10.1007/s00059-013-3758-6
Özet
Slow coronary flow (SCF) is an angiographic finding characterized by delayed opacification of the epicardial coronary arteries without obstructive coronary disease. Resistin, an adipocytokine, plays a major role besides low-grade inflammation in atherosclerotic vascular processes and may be of importance in other coronary pathologies such as SCF.
The present study was cross-sectional and observational, consisting of 70 individuals who underwent coronary angiography and had angiographically normal coronary arteries of varying coronary flow rates. The study included 50 patients with isolated SCF and 20 control participants with normal coronary flow (NCF).
There were no statistically significant differences between the SCF and NCF groups with respect to age, gender, presence of hypertension or diabetes mellitus, and smoking habit, except for increased creatinine levels (p = 0.014). The serum resistin level was significantly higher in the SCF group than in the NCF group (8.4 +/- 7.2 vs. 5.4 +/- 2.6 ng/ml, p = 0.014). Ln-transformed resistin levels correlated positively with left anterior descending (LAD) coronary artery TIMI frame count (TFC) (r = 0.408, p < 0.001) as well as with glucose (r = 0.340, p = 0.004), creatinine (r = 0.248, p = 0.044), and C-reactive protein (CRP; r = 0.283, p = 0.023) levels, and negatively with LAD coronary flow velocity (r = -aEuro parts per thousand 0.314, p = 0.009). When multivariate analyses were performed, in linear regression analysis, ln-resistin was associated with a longer TFC [beta (standardized regression coefficient): 0.404, p = 0.001] and lower coronary flow velocity (beta: -aEuro parts per thousand 0.280, p = 0.035); in logistic regression analysis, ln-resistin was an independent predictor of the presence of SCF (OR: 6.692, 65 %CI: 1.117-40.1, p = 0.037).
We demonstrated, for the first time, a significant increase in serum resistin levels in patients with SCF compared to subjects with NCF. We believe that further studies are needed to clarify the role of resistin in patients with SCF.
Anahtar Kelimeler
Slow coronary flow | Resistin | Adipokines | C-reactive protein | Coronary angiography